17βE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFκB-dependent pathway

Molecular and Cellular Endocrinology

Volumn 317, Issue 1-2, 2010, Pages 31-43

  Zhang, Hui ^a   Zhao, Xingbo ^a   Liu, Shu ^a   Li, Jijun ^a   Wen, Zeqing ^a   Li, Mingjiang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

17 Estradiol; Endometriosis; MAPK ERK p ERK; NF B; PI3K AKt p AKt; PTEN

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ESTRADIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PYRROLIDINE DITHIOCARBAMATE; TETRAZOLIUM; UO 126; DNA; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL FRACTIONATION; CELL NUCLEUS; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; CELL NUCLEUS; CELL PROLIFERATION; DNA; ENDOMETRIOSIS; ENZYME ACTIVATION; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSCRIPTION, GENETIC;

EID: 74749104852     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.11.009     Document Type: Article

References (57)

1. Bergqvist A., Jeppsson S., and Ljungberg O. Histochemical demonstration of estrogen and progesterone binding in endometriotic tissue and in uterine endometrium: a comparative study. J. Histochem. Cytochem. 33 2 (1985) 155-161
2. Bruse C., Guan Y., Carlberg M., Carlström K., and Bergqvist A. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. Fertil Steril. 1 (2005) 1155-1160
3. Bulun S.E., Zeitoun K.M., Takayama K., and Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J. Mol. Endocrinol. 25 1 (2000) 35-42
4. Brasier A.R. The NF-kappaB regulatory network. Cardiovasc. Toxicol. 6 2 (2006) 111-130
5. Cakmak H., Guzeloglu-Kayisli O., Kayisli U.A., and Arici A. Immune-endocrine interactions in endometriosis. Front. Biosci. 1 (2009) 429-443
6. Chakraborty A., and Guha S. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Urology 69 6 (2007) 1210-1215
7. Chang C.J., Mulholland D.J., Valamehr B., Mosessian S., Sellers W.R., and Wu H. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol. Cell. Biol. 28 10 (2008) 3281-3289
8. Chow L.M.L., and Baker S.J. PTEN function in normal and neoplastic growth. Cancer Lett. 241 (2006) 184-196
9. Chung J.H., Ostrowski M.C., Romigh T., Minaguchi T., Waite K.A., and Eng C. The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum. Mol. Genet. 15 17 (2006) 2553-2559
10. Eng C. PTEN: one gene, many syndromes. Hum. Mutat. 22 (2003) 183-198
11. Escárcega R.O., Fuentes-Alexandro S., García-Carrasco M., Gatica A., and Zamora A. The transcription factor nuclear factor-kappa B and cancer. Clin. Oncol. (R. Coll. Radiol.) 19 2 (2007) 154-161
12. Faissner A., Heck N., Dobbertin A., and Garwood J. DSD-1-Proteoglycan/Phosphacan and receptor protein tyrosine phosphatase-beta isoforms during development and regeneration of neural tissues. Adv. Exp. Med. Biol. 557 (2006) 25-53
13. Gentilini D., Busacca M., Di Francesco S., Vignali M., Viganò P., and Di Blasio A.M. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol. Hum. Reprod. 13 5 (2007) 317-322
14. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25 51 (2006) 6680-6684
15. Gimm O., Perren A., Weng L.P., Marsh D.J., Yeh J.J., Ziebold U., Gil E., Hinze R., Delbridge L., Lees J.A., Mutter G.L., Robinson B.G., Komminoth P., Dralle H., and Eng C. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol. 156 5 (2000) 1693-1700
16. Goldman M.B., and Cramer D.W. The epidemiology of endometriosis. Prog. Clin. Biol. Res. 323 (1990) 15-31
17. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A.F., and Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57 (1997) 3660-3663
18. Halme J., Hammond M.G., Hulka J.F., Raj S.G., and Talbert L.M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol. 64 (1984) 151-154
19. Honda H., Barrueto F.F., Gogusev J., Im D.D., and Morin P.J. Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium, possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod. Biol. Endocrinol. 6 (2008) 59
20. Jin X., Gossett D.R., Wang S., Yang D., Cao Y., Chen J., Guo R., Reynolds R.K., and Lin J. Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells. Br. J. Cancer 91 10 (2004) 1808-1812
21. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., and Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell. Dev. Biol. 17 (2001) 615-675
22. Kim S.K., Su L.K., Oh Y., Kemp B.L., Hong W.K., and Mao L. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene 16 (1998) 89-93
23. Kim S., Domon-Dell C., Kang J., Chung D.H., Freund J.N., and Evers B.M. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J. Biol. Chem. 279 (2004) 4285-4291
24. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., Fushiki S., Osawa Y., and Honjo H. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol. Reprod. 57 3 (1997) 514-519
25. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
26. Lian Z., and Di Cristofano A. Class reunion: PTEN joins the nuclear crew. Oncogene 24 (2005) 7394-7400
27. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273 (1998) 13375-13378
28. Maehama T. PTEN: its deregulation and tumorigenesis. Biol. Pharm. Bull. 30 (2007) 1624-1627
29. Martini M., Ciccarone M., Garganese G., Maggiore C., Evangelista A., Rahimi S., Zannoni G., Vittori G., and Larocca L.M. Possible involvement of hMLH1, p16 (INK4a) and PTEN in the malignant transformation of endometriosis. Int. J. Cancer 102 4 (2002) 398-406
30. Matsuzaki S., Canis M., Vaurs-Barrière C., Boespflug-Tanguy O., Dastugue B., and Mage G. DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil. Steril. 84 (2005) 1180-1190
31. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., and Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 85 6 (2000) 2334-2338
32. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A., Weng L.P., and Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92 (2000) 924-930
33. Myers M.P., Stolarov J.P., Eng C., Li J., Wang S.I., Wigler M.H., Parsons R., and Tonks N.K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9052-9057
34. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81 (1996) 174-179
35. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Fertil. Steril. 1 (1950) 3-25
36. Obata K., Morland S.J., Watson R.H., Hitchcock A., Chenevix-Trench G., Thomas E.J., and Campbell I.G. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58 10 (1998) 2095-2097
37. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 2 (2000) 153-183
38. Perren A., Komminoth P., Saremaslani P., Matter C., Feurer S., Lees J.A., Heitz P.U., and Eng C. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am. J. Pathol. 157 4 (2000) 1097-1103
39. Ramaswamy S., Nakamura N., Vazquez F., Batt D.B., Perera S., Roberts T.M., and Sellers W.R. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U.S.A. 96 5 (1999) 2110-2115
40. Salvesen H.B., MacDonald N., Ryan A., Jacobs I.J., Lynch E.D., Akslen L.A., and Das S. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int. J. Cancer 91 1 (2001) 22-26
41. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol. 14 (1927) 422-469
42. Sato N., Tsunoda H., Nishida M., Morishita Y., Takimoto Y., Kubo T., and Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60 (2000) 7052-7056
43. Sato N., Nishida M., and Noguchi M. An approach to early genetic alterations in precancerous cells. Hum. Cell 13 3 (2000) 103-108
44. Sheikh M.S., and Huang Y. Death receptor activation complexes: it takes two to activate TNF receptor 1. Cell Cycle 2 6 (2003) 550-552
45. Shen W.H., Balajee A.S., Wang J., Wu H., Eng C., Pandolfi P.P., and Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128 1 (2007) 157-170
46. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., and Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell 8 (2001) 317-325
47. Strathy J.H., Molgaard C.A., Coulam C.B., and Melton III L.J. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil. Steril. 38 (1982) 667-672
48. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9 1 (2005) 59-71
49. Sugawara J., Fukaya T., Murakami T., Yoshida H., and Yajima A. Increased secretion of hepatocyte growth factor by eutopic endometrial stromal cells in women with endometriosis. Fertil. Steril. 68 3 (1997) 468-472
50. Tian B., and Brasier A.R. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog. Horm. Res. 58 (2003) 95-130
51. The American Fertility Society. Classification of endometriosis. Fertil Steril. 32 6 (1997) 633-634
52. Vasudevan K.M., Gurumurthy S., and Rangnekar V.M. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol. Cell Biol. 24 (2004) 1007-1021
53. Virolle T., Adamson E.D., Baron V., Birle D., Mercola D., Mustelin T., and de Belle I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3 (2001) 1124-1128
54. Xia D., Srinivas H., Ahn Y.H., Sethi G., Sheng X., Yung W.K., Xia Q., Chiao P.J., Kim H., Brown P.H., Wistuba I.I., Aggarwal B.B., and Kurie J.M. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NFκB-dependent pathway. J. Biol. Chem. 282 (2007) 3507-3519
55. Yagyu T., Tsuji Y., Haruta S., Kitanaka T., Yamada Y., Kawaguchi R., Kanayama S., Tanase Y., Kurita N., and Kobayashi H. Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis. Int. J. Gynecol. Cancer 16 4 (2006) 1545-1551
56. Yang Z.Z., Tschopp O., Baudry A., Dümmler B., Hynx D., and Hemmings B.A. Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 32 Pt 2 (2004) 350-354
57. Yoshino O., Osuga Y., Koga K., Hirota Y., Hirata T., Ruimeng X., Na L., Yano T., Tsutsumi O., and Taketani Y. FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J. Reprod. Immunol. 72 1-2 (2006) 85-93